Literature DB >> 22674113

Dramatic weight loss associated with commencing clozapine.

John Lally1, Colm McDonald.   

Abstract

The authors report the case of a 44-year-old man with a long history of chronic enduring schizophrenia who experienced dramatic weight loss after commencing treatment with clozapine, an antipsychotic medication characteristically associated with the greatest degree of weight gain among medical treatments for schizophrenia. He was obese with a body mass index (BMI) of 41.5 kg/m(2), but after commencing clozapine therapy he experienced an improvement in psychotic symptoms and 40% loss of his body weight attained through an altered diet and exercise regime, which resulted in him attaining a normal BMI of 24.8 kg/m(2).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22674113      PMCID: PMC3214220          DOI: 10.1136/bcr.09.2011.4790

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  The role of a fitness intervention on people with serious psychiatric disabilities.

Authors:  Gary S Skrinar; Nancy A Huxley; Dori S Hutchinson; Eliza Menninger; Patrick Glew
Journal:  Psychiatr Rehabil J       Date:  2005

2.  Clozapine producing weight loss: a case series with possible clinical implications - a hypothesis.

Authors:  N Thomas; J R Ravan; P Jebaraj; D Braganza
Journal:  J Postgrad Med       Date:  2009 Oct-Dec       Impact factor: 1.476

Review 3.  Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

Authors:  Christine Rummel-Kluge; Katja Komossa; Sandra Schwarz; Heike Hunger; Franziska Schmid; Claudia Asenjo Lobos; Werner Kissling; John M Davis; Stefan Leucht
Journal:  Schizophr Res       Date:  2010-08-07       Impact factor: 4.939

4.  Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.

Authors:  M Chakos; J Lieberman; E Hoffman; D Bradford; B Sheitman
Journal:  Am J Psychiatry       Date:  2001-04       Impact factor: 18.112

5.  Clozapine and weight gain.

Authors:  D S Umbricht; S Pollack; J M Kane
Journal:  J Clin Psychiatry       Date:  1994-09       Impact factor: 4.384

Review 6.  Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.

Authors:  Gavin P Reynolds; Shona L Kirk
Journal:  Pharmacol Ther       Date:  2009-11-17       Impact factor: 12.310

7.  Clozapine-associated weight loss.

Authors:  R Hanwella; V de Silva; C Wijeratne; T Ketharanathan; J de Silva
Journal:  J Psychopharmacol       Date:  2009-03-05       Impact factor: 4.153

8.  Emergence of obsessive compulsive symptoms during treatment with clozapine.

Authors:  R W Baker; K N Chengappa; J W Baird; S Steingard; M A Christ; N R Schooler
Journal:  J Clin Psychiatry       Date:  1992-12       Impact factor: 4.384

Review 9.  Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.

Authors:  H A Nasrallah
Journal:  Mol Psychiatry       Date:  2007-09-11       Impact factor: 15.992

10.  Association of initial antipsychotic response to clozapine and long-term weight gain.

Authors:  Ya Mei Bai; Chao-Cheng Lin; Jen-Yeu Chen; Chih-Yuan Lin; Tung-Ping Su; Pesus Chou
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242

View more
  3 in total

Review 1.  Significant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subject.

Authors:  Tongeji E Tungaraza
Journal:  Ther Adv Psychopharmacol       Date:  2016-05-31

2.  Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".

Authors: 
Journal:  Neuropsychopharmacol Rep       Date:  2021-08-12

3.  Clozapine-induced dysphagia with secondary substantial weight loss.

Authors:  Mugtaba Osman; Vekneswaran Devadas
Journal:  BMJ Case Rep       Date:  2016-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.